NFKB1 and neoplasm: However, chemotherapy has severe toxic side effects and may cause inflammatory responses induced by NF-κB activation and chemokine upregulation, leading to treatment resistance and tumor recurrence, thus limiting their effectiveness in inducing ICD to enhance ICB therapy 21-23.